Can you provide the last earnings date for AC IMMUNE SA?
AC IMMUNE SA (ACIU) last reported earnings on 3/13/2026.
NASDAQ:ACIU • CH0329023102
Past quarterly earnings results for AC IMMUNE SA (ACIU), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in CHF): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.13 | -0.17 | 24.30% | 18.75% | 338K | 1.168M | -71.06% | -70.27% |
| Q3 2025 | -0.16 | -0.19 | 17.94% | -420.00% | 939K | 829.556K | 13.19% | -96.32% |
| Q2 2025 | -0.21 | -0.18 | -18.00% | 8.70% | 1.306M | 2.02M | -35.35% | 90.10% |
| Q1 2025 | -0.19 | -0.21 | 9.14% | -5.56% | 990K | 329.644K | 200.32% | - |
| Q4 2024 | -0.16 | -0.19 | 16.28% | -220.00% | 1.137M | 756.932K | 50.21% | -92.32% |
| Q3 2024 | 0.05 | -0.20 | 125.04% | 127.78% | 25.485M | 1.514M | 1,583.29% | - |
| Q2 2024 | -0.23 | 0.27 | -183.77% | -15.00% | 687K | - | - | |
| Q1 2024 | -0.18 | -0.14 | -30.60% | 14.29% | 5.433M | -100.00% | - | |
| Q4 2023 | -0.05 | -0.12 | 56.75% | 78.26% | 14.801M | 10.234M | 44.63% | - |
| Q3 2023 | -0.18 | 0.03 | -787.46% | -12.50% | 21.624M | -100.00% | -100.00% | |
| Q2 2023 | -0.20 | -0.20 | 0.63% | 13.04% | 1.7M | -100.00% | - | |
| Q1 2023 | -0.21 | -0.23 | 10.29% | 8.70% | - | - | ||
| Q4 2022 | -0.23 | -0.26 | 10.53% | 17.56% | 1.632M | -100.00% | - | |
| Q3 2022 | -0.16 | -0.25 | 35.13% | 27.27% | 3.93M | 237.997K | 1,551.28% | - |
| Q2 2022 | -0.23 | -0.24 | 2.94% | 11.54% | 237.997K | -100.00% | - | |
| Q1 2022 | -0.23 | -0.23 | -1.78% | - | 237.997K | -100.00% | - | |
| Q4 2021 | -0.28 | 0.10 | -367.77% | -3.33% | 28.662M | -100.00% | -100.00% | |
| Q3 2021 | -0.22 | -0.28 | 20.70% | 8.33% | 1.782M | -100.00% | -100.00% | |
| Q2 2021 | -0.26 | -0.25 | -6.07% | -18.18% | 1.456M | -100.00% | -100.00% | |
| Q1 2021 | -0.23 | -0.24 | 2.18% | -109.09% | 3.448M | -100.00% | -100.00% | |
| Q4 2020 | -0.27 | -0.25 | -7.07% | - | 940K | 1.324M | -29.00% | - |
| Q3 2020 | -0.24 | -0.25 | 4.74% | - | 1.12M | 867K | 29.18% | - |
| Q2 2020 | -0.22 | -0.25 | 12.58% | - | 1.28M | 510K | 150.98% | - |
| Q1 2020 | -0.11 | -0.15 | 24.76% | - | 12.41M | 13.107M | -5.32% | - |
Notes
AC IMMUNE SA (ACIU) last reported earnings on 3/13/2026.
AC IMMUNE SA (ACIU) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, AC IMMUNE SA (ACIU) has beaten EPS estimates in 3 out of 4 releases.